|
US5324520A
|
|
Intragingival delivery systems for treatment of periodontal disease
|
|
US5175000A
|
|
Free amine benzophenanthridine alkaloid compositions
|
|
US5066483A
|
|
Oral rinse compositions
|
|
AU5966190A
|
|
Intragingival delivery systems for treatment of periodontal disease
|
|
IE900690L
|
|
Oral rinse compositions
|
|
NZ232572A
|
|
Oral rinse composition containing a benzophenanthridine alkaloid extract from sanguinaria canadesis
|
|
US5013553A
|
|
Drug delivery devices
|
|
US5077049A
|
|
Biodegradable system for regenerating the periodontium
|
|
BR8900705A
|
|
Process to extract an alkaloid from a plant
|
|
NZ227827A
|
|
Extracting alkaloids from plants
|
|
KR0139537B1
|
|
Production of high purity alkaloids
|
|
DK39489D0
|
|
Procedure for extracing alkaloids from plant material
|
|
US4975271A
|
|
Muscosal delivery systems for treatment of periodontal disease
|
|
IL86802D0
|
|
Drug delivery devices
|
|
AU1119688A
|
|
Method for inhibiting the release of histamine
|
|
AU1119588A
|
|
Method for inhibiting bone resorption and collagenase release
|
|
DK50388D0
|
|
Using a benzo-c-phenanthridine alkaloid compound for the preparation of a pharmaceutical agent
|
|
EP0326628A1
|
|
Method for inhibiting the release of histamine
|
|
EP0326627A1
|
|
Method for inhibiting bone resorption and collagenase release
|
|
DK50288D0
|
|
Use of a benzo-c-phenanthridinalkaloid for the preparation of a pharmaceutical agent
|
